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We present descriptions of two human Mycobacterium microti infections: one of a patient with pulmonary
disease and one of a patient with osteomyelitis of the hip. Both patients had acid-fast bacilli and a positive
Mycobacterium tuberculosis complex PCR from clinical specimens, but mycobacterial cultures remained nega-
tive. The microbiological diagnosis was established by molecular methods.
CASE REPORTS
Patient 1 was a 60-year-old human immunodeficiency virus-
negative man who was admitted for a diagnostic pulmonary
biopsy. One year prior to admission, the patient suffered from
a 1-month period of weight loss, high fever, and night sweats.
At that time, a chest X ray showed an infiltrate in his right lung
and he was treated with a 6-month course of amoxicillin for a
presumed pulmonary actinomycosis, which was diagnosed by
cytological examination of a bronchoalveolar lavage sample.
The infiltrate decreased during therapy and cleared 6 months
after therapy. During follow-up, 6 months after cessation of
amoxicillin, he developed a new lesion in his left upper lobe
suspected of malignancy, with increased 18-fluordeoxyglucose
uptake on a positron emission tomography scan. The lesion was
resected by thoracotomy for diagnostic purposes. Histopathologic
examination revealed granulomatous necrotic inflammatory
tissue with acid-fast bacilli (AFB); malignant cells were not
found. A Mycobacterium tuberculosis (MTB) complex PCR tar-
geting the IS6110 sequence was positive (10). The lung tissue
specimen was cultured in liquid medium (Bactec MGIT; Bec-
ton Dickinson [BD], Sparks, MD) and on agar-based media
(Middlebrook and Cohn 7H10; BD) and egg-based media (Co-
letsos plus ossein agar; Bio-Rad, Marnes-la-Coquette, France).
All cultures were incubated at 37°C for 8 weeks. After these
cultures remained negative, a second attempt at mycobacterial
culture was performed on tissue specimens stored at 20°C
using the same media and 9 weeks of incubation. Again, my-
cobacterial cultures remained negative. Following the positive
AFB staining and PCR results from the lung tissue specimens,
sputum samples were collected on three separate occasions
that were negative for AFB and mycobacterial culture. The
patient was treated with isoniazid, rifampin, and ethambutol
for a total of 6 months and pyrazinamide for the initial 2
months. One month after completion of therapy, the patient
was well and without symptoms.
Patient 2 was a 58-year-old man who was admitted for a total
hip prosthesis because of avascular necrosis of his right hip.
Nineteen months earlier, corticosteroid treatment was started
for polymyalgia rheumatica. He developed pain in his right hip
and night sweats 7 months before admission and 3 months
after cessation of corticosteroids. He reported 30 kg of weight
loss since the onset of pain in the hip. He had no pulmonary
complaints and no abnormalities on chest X-ray examination.
At surgery, a femoral head resection was performed, but no
prosthesis was implanted since an infection was suspected in-
traoperatively. A Girdlestone situation was created. Synovial
fluid and surgical tissue specimens showed sharply curved AFB
(Fig. 1A). The synovial fluid was positive for MTB complex by
the IS6110 PCR. Histopathologic examination showed a gran-
ulomatous necrotic osteomyelitis and synovitis with AFB.
Synovial fluid and the four surgical tissue specimens were
treated with 1.5% NaOH and were routinely cultured in liquid
medium (Bactec MGIT) at 37°C for 8 weeks. After these
cultures remained negative, all specimens, which were stored
at 20°C, were cultured a second time without NaOH pre-
treatment in liquid medium and on agar-based and egg-based
media at 37°C. A repeat culture of the synovial fluid was also
performed on agar-based and egg-based media at 30°C, 37°C,
and 42°C. Finally, the synovial fluid was inoculated in liquid
medium (MYCO/F-lytic medium; BD) using the Bactec 9120
automated culture system (BD). These cultures were incu-
bated for 22 weeks. All cultures remained negative. Three
sputum specimens collected after surgery were negative for
AFB and mycobacterial culture. Treatment with isoniazid,
ethambutol, levofloxacin, and amikacin was initiated because
of the presence of liver test abnormalities of unknown etiology.
After 3 weeks, the liver test abnormalities improved and
amikacin and levofloxacin were stopped and replaced with
rifampin and moxifloxacin. Treatment was continued for a
total of 9 months. Postoperatively, wound healing was de-
layed and complicated by Staphylococcus aureus infections
for which the patient underwent surgical debridement and
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antimicrobial treatment. Mycobacteria were not detected in
the surgical specimens.
In both cases, Mycobacterium microti infection was suspected
when all culture attempts remained negative and review of the
microscopy showed typically curved mycobacteria (Fig. 1).
Therefore, the GenoType MTBC reverse hybridization assay
(Hain Lifescience GmbH, Nehren, Germany) was performed
directly on the lung biopsy specimen and the pus from the hip.
The hybridization patterns were consistent with M. microti
infection.
Patient histories were reevaluated with respect to possible
exposure to MTB. Both patients had no recent contacts with
known tuberculosis patients, and they had not traveled to
countries with a high prevalence of tuberculosis. There was no
risk of occupational exposure to tuberculosis patients: patient
1 worked as a construction supervisor and patient 2 as a sales
manager. Patient 2 did have contact with a cousin suffering
from active tuberculosis 40 years ago. The patients were un-
aware of any recent or past contacts with or occupational
exposure to rodents. In both cases, no potential source of
infection was identified by the public health authorities. Close
contacts who were screened for tuberculosis had no signs of
active tuberculosis, and the purified protein derivative skin
tests were negative.
We describe a patient with a pulmonary infection and the
first case of human osteomyelitis caused by M. microti. Most
likely both patients presented with reactivation of a latent
infection, considering their clinical presentation. No human
source of these infections could be established, and no contacts
with small rodents were reported. Sputum samples from both
patients were negative for AFB, and no secondary cases were
identified in the direct environment.
M. microti is a pathogen of rodents causing disease in voles,
wood mice, and shrews, with a prevalence ranging from 5 to
50% in the United Kingdom (1). M. microti has long been
considered not to be a human pathogen (12). However, several
case reports have now been published describing M. microti
infections in immunocompromised and immunocompetent pa-
tients. Most patients suffered from pulmonary infection, but
disseminated disease and peritonitis in a patient on peritoneal
dialysis have also been described (2–5, 7, 12, 13). In most cases,
animal reservoirs have been implicated as the likely source of
human M. microti infections, but the possibility of human-to-
human transmission has been suggested (12).
M. microti is a member of the MTB complex, which is com-
posed of the genetically closely related species M. tuberculosis,
M. bovis, M. canetti, M. africanum, M. microti, and M. pinnipe-
dii. M. microti has a typical sickle-shaped, spiral or S-like mor-
phology in acid-fast stains of fresh material, but this property
may be lost upon subculture (8). It is an extremely slow-grow-
ing Mycobacterium, and in most reported cases, cultures did
not turn positive within the incubation time of 8 weeks that
is routinely used in most clinical microbiology laboratories.
In vitro, growth can be best obtained using pyruvate-supple-
mented media, which can be explained by the intrinsic lack
of pyruvate kinase activity (6). Biochemically, M. microti is
difficult to separate from other members of the MTB complex,
and the widely used IS6110 PCR for identification of M. tu-
berculosis, which is positive with all members of the MTB
complex, cannot make this distinction (8, 10). As already sug-
gested by others, human M. microti infection has probably been
underestimated, considering the need for extended culture
procedures and the difficulty to identify the different species
within the MTB complex by routine microbiology methods
(12). M. microti has only recently been described as a human
pathogen after the introduction of novel molecular methods
for identification and direct detection of mycobacteria in clin-
ical specimens (12).
The clinical specimens of both patients were positive for
AFB and the IS6110 PCR. The AFB appeared typically curved,
but this was only noticed after reexamination of the slides when
cultures remained negative despite multiple attempts, use of
pyruvate-supplemented media, and prolonged incubation. Infec-
tion with M.microti was then suspected, and specimens from both
patients were sent to the Dutch national reference laboratory for
mycobacterial cultures (National Institute of Public Health and
the Environment [RIVM]) for further analysis by the Geno-
Type MTBC reverse hybridization assay. This assay was devel-
oped to distinguish the members of the MTB complex and is
based on detection of an MTB complex-specific 23S rRNA
gene fragment, gyrB DNA sequence polymorphisms, and RD1
(region of difference 1) deletion of M. bovis BCG by PCR and
reverse hybridization (9). The method has also been evaluated
for use on AFB-positive clinical specimens (11). The speci-
mens from both patients showed the specific hybridization
pattern for M. microti.
In conclusion, molecular methods used directly on clinical
FIG. 1. Representative photographs of the Ziehl-Neelsen stains of
pus from the hip from patient 2 (A) and the lung biopsy specimen from
patient 1 (B). Magnification, 630.
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specimens may readily establish the microbiological diagno-
sis of M. microti infection. M. microti should be suspected in
case of AFB-positive specimens with positive PCR results
for the MTB complex, when either cultures remain negative
in the absence of tuberculostatic drugs or typical curved
AFB are present. These recent molecular techniques will
facilitate the investigation of the true incidence and epide-
miology of human M. microti infections.
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